Abstract
Introduction
diac pacing [10] , supporting the role of K channels in ATP vasodilator reserve when metabolic stimuli are enhanced. ATP-sensitive K channels (K ) play an important Intriguingly, however, blockade of K channels by GLI ATP ATP role in the regulation of basal coronary tone [1] [2] [3] and does not inhibit exercise-induced coronary flow reserve contribute to vasodilation under conditions of increased [6, 7, 11] , due in large part to increases or an enhanced role metabolic demand [4] or ischemia [5] . In conscious dogs, of adenosine and nitric oxide (NO)-dependent dilation. inhibition of these channels by glibenclamide (GLI) lowers
This has led to the concept of redundancy of dilatorresting coronary flow by 30-50% [6, 7] . Glibenclamide reserve mechanisms, with one or another pathway compenalso abolishes vasodilation associated with sating for the reduced effectiveness of another [12] . b -adrenoceptor stimulation [8, 9] and incremental carAn important signalling mechanism that could play a 1 role in this behaviour is the rise in coronary perfusion pulsatility. During exercise, the arterial pulse pressure (PP) itself modestly increase coronary flow by an NO-depenthe perfusion line was measured by micromanometer (SPC dent mechanism [16] . This effect is considerably amplified 350, Millar Inst., TX), and used to calculate the feedback by low-levels of adenosine [17] . It has been reported that error signal for servo-control. The servo-command signal both shear-stress stimulated [1] and agonist-evoked [5, 19] was generated from the central aortic pressure wave. NO release are unaffected by glibenclamide, and that This waveform was digitally stored to memory, modi-1 K -channel blockade effects are principally confined to fied to achieve the desired pulse amplitude, and then ATP the distal microvascular bed [20] [21] [22] . Thus, it is feasible ''played back'' while maintaining synchrony with LV that enhanced pulsatility of coronary flow might trigger contraction. We have previously shown that alterations of NO-mediated vasodilator responses, offsetting distal resistregional (or global) coronary PP does not itself alter 1 ance rise from K blockade. The present study tested myocardial wall function or energetics [16, 17, 25] . ATP this hypothesis, employing an in vivo model in which the Chamber function was minimally changed, as hearts pulsatility of coronary flow was directly and independently ejected into the native vasculature under all conditions. controlled by a servo-pump, either in the presence of GLI Blood temperature in the servo-system was maintained at alone or in combination with NO-inhibition. To test the 378C, with blood gases matching those of the systemic specificity of vasoconstriction / pulsatility interactions, furcirculation. ther studies were performed with arginine-vasopressin (AVP) or quinacrine (QUI). Both agents were chosen as 2.1. Pharmaceuticals they induce diffuse vasoconstriction without inhibiting receptor-mediated NO release (i.e. by acetylcholine G N -monomethyl-L-arginine (L-NMMA; CalBiochem, La [23, 24] ).
Jolla CA), arginine-vasopressin, quinacrine, acetylcholine (Sigma Chemical Co., St. Louis, MO), and adenosine (Adenocard, Fujisawa), were each dissolved in isotonic 2. Materials and methods saline. GLI [Sigma] was prepared in deionized water with pH adjusted to 8-8.5 with 0.1 N NaOH and 0.1 N HCl. The protocol was reviewed and approved by the Animal Pinacidil (RBI, Natick, MA) was dissolved in dimethylsulCare and Use Committee of the Johns Hopkins University phoxide (DMSO) and isotonic saline, with a final conand conformed to the Guide for the Care and Use of centration of DMSO of ,0.01%. Vehicle was tested Laboratory Animals (NIH publication N. 85-23, revised independently and had no effect on coronary flow. All the 1985). The servo-system used to regulate in situ coronary drugs were administered intracoronary through a side-port pulsatile perfusion has been previously reported in the in the servo-perfusion line. detail [16] . Briefly, adult mongrel dogs (n531; weight 28-36 kg) were anaesthetized with pentobarbital (30 mg / kg i.v.) and fentanyl (50 mg / kg i.v.) and ventilated with 2.2. Experimental protocols enhanced inspired oxygen. Ventilation was adjusted to yield physiological arterial pO , pCO , and pH. Left After servo-perfusion was established in the isolated 2 2 external jugular and femoral veins were cannulated for coronary bed, the pulse pressure was set to 40 mm Hg, and fluid administration and anaesthesia maintenance. Inconditions stabilized for 15-20 min. Data were then domethacin (50 mg i.m.) was then administered. Both obtained at steady-state with the servo-pump generating femoral, left carotid, and left subclavian artery, were PPs of either 40 or 100 mm Hg. Data were recorded 4-5 cannulated for withdrawal of oxygenated blood into the min following a change in PP, with repeat recordings made servo-pump, and for blood sampling and pressure moniat each PP to confirm reproducibility. Baseline data were toring in the aortic root and LV cavity.
obtained in all animals. PP-flow responses during coAfter heparinization (8000 IU bolus, 1000 IU / h), the infusion of various agents were obtained in subsets of LAD was cannulated and left carotid arterial blood dithese animals. verted through this cannula to maintain flow while the To test whether enhanced flow pulsatility offset constric- adenosine [26] 5-25 mg / min i.c., n55)-induced flow Blood then passed through a filter, heat exchanger, and elevation. Pinacidil and adenosine flow responses declined one-way valve, and into a chamber with a movable floor by 80% and 70%, respectively. To test the role of NOthat was linked to a linear motor (Ling Apparatus, CT). stimulation, GLI infusion was stopped and L-NMMA Digital real-time feedback was used to position the motor infused (n55; 5 mg / min320 min, i.c.). Data were then and generate the desired pulse pressure. Blood then exited measured at both PPs, GLI was re-infused, and PP again the chamber to perfuse the LAD cannula. Pressure within varied in the presence of both agents. In two additional subsets, the protocol was repeated using either AVP (0.5-2 3.2. Glibenclamide and perfusion pulsatility mg / min) or QUI (6.7 mg/kg/min320 min; both n58). Each agent was infused intracoronary, and titrated to intracellular Ca release [27, 28] ; while K inhibition is higher perfusion pulsatility are denoted by shading. At ATP less prominent [24] . AVP can also modestly reduce venbaseline, elevating PP generated higher flow during tricular contractility [29] .
systolic ejection, but little net if not a slight decline in flow 21 1 Quinacrine inhibits Ca and ATP sensitive K chanduring diastole. nels [30, 31] and PLA [32] , the latter reducing generation However, in the presence of GLI, higher pulsatility 2 of arachidonic acid metabolites that are linked with smooth enhanced both systolic and diastolic flow, with the net muscle hyperpolarization and relaxation [33, 34] . Thus both result being a much larger increase in mean coronary flow agents induce more diffuse constriction than GLI.
at an identical mean perfusion pressure. Fig. 1B provides To confirm that neither AVP nor QUI acted by direct mean data. Increasing pulsatility under basal conditions inhibition of NO release, we determined the vasodilator resulted in a 6669% increase in flow during the systolicresponse to ACh (300 mg i.c.) in animals before and after period, but an 21162% decline in diastolic-flow. After AVP and QUI (n55). In these same animals, we tested GLI, enhanced pulsatility increased flow during both whether the effects of L-NMMA on inhibiting pulsesystole (166626%) and diastole (12865%) (both P, mediated and ACh-induced vasorelaxation were altered by 0.02 vs. control). Importantly, both systolic and diastolic co-treatment with AVP. If so, this would suggest a primary perfusion periods were unchanged since only the pulse NO-inhibition effect of AVP itself. Data were obtained at amplitude was altered by this manoeuver. PP540 or 100 mm Hg with and without AVP, both before Net effects on mean coronary flow are shown in Fig. 1C . and after L-NMMA.
At baseline pulsatility (40 mm Hg), flow was 3763 ml/ min, and this fell significantly to 2564 ml / min after GLI administration. Mean flow was slightly higher (4162 ml/ 2.3. Data analysis and statistics min) with enhanced perfusion pulsatility, and remained unaltered despite GLI (4564 ml / min, P5NS). Thus, Data were digitized at 200 Hz and analysed off-line with elevating coronary perfusion pulsatility reversed the vascustom software. Mean and pulsatile coronary flow, oconstrictive effect of glibenclamide. systolic, diastolic, and mean coronary pressure, LV pressure and aortic flow were measured in each study. For comparison of paired samples in each group and between 3.3. Effect of L-NMMA and GLI1L-NMMA on pulsatile groups, Student's t test for paired and unpaired data were perfusion response used, with a Bonferroni correction for multiple comparisons. Data are presented as mean6S.E.M..
A potential mechanism for reversal of GLI-induced vasoconstriction by enhanced pulsatility was a greater role of mechanically-stimulated NO-release. GLI effects dominate in distal resistance beds following the distribution of 
Results
K channels, which could potentially maintain more ATP proximal NO-responsiveness to enhanced pulsatility. To 3.1. Chamber hemodynamics and pulsatility test this hypothesis, L-NMMA was first infused alone, then co-infused with GLI, and perfusion pulsatility varied. Left ventricular systolic pressure averaged 12764 mm NOS-inhibition alone had no significant effect on mean Hg in control, and was similar with all interventions coronary flow at a PP of 40 mm Hg, but modestly lowered (13063, 12666, 12368, 122613 for i.c. GLI, mean flow at PP5100 mm Hg (2561%, P,0.001). Flow glibenclamide1L-NMMA, AVP, and QUI, respectively). augmentation due to PP declined from 11462% to Heart rates generally ranged between 110 and 120 / min.
19%61.5 after L-NMMA, (236%; P,0.001). Flow Importantly, there were no significant changes in chamber responses to ACh infusion (300 mg i.c.) were also reduced hemodynamics associated with alterations in perfusion PP by 3963.8%, consistent with prior results [16] . for any of the conditions. We have previously reported
In the presence of L-NMMA, increasing perfusion regional function is similarly unaltered by this manoeuver, pulsatility no longer offset vasoconstriction induced by and that PP-flow responses are not influenced by even GLI. Fig. 2A displays phasic coronary flow waveforms at moderate changes in regional or global contractile state the two pulse pressures. Unlike the results with GLI alone, [16, 17] .
combined GLI and L-NMMA no longer resulted in en- flow by 24363%, (P,0.01), matching changes induced Mean coronary flow (Fig. 2B) at a PP of 40 mmHg fell by GLI. However, a very similar 24464% reduction in from 3663 to 1362 ml / min (26068%; P,0.01) in the mean flow was also observed at higher PP (P5NS vs. presence of GLI1L-NMMA, and similar constriction was PP240 mm Hg). Flow during systole rose with higher PP now also observed at higher pulsatility (3964 vs. 2369 similar to responses with GLI; however diastolic flow ml / min, 24066%; P,0.001).
declined .30% offsetting this change (Fig. 3B, upper) . Analogous data were obtained with QUI (Fig. 3, lower 
Interaction of AVP and quinacrine and perfusion
panels) with flow reduction at 40 mm Hg PP being similar pulsatility to that observed at higher PP (22366.5% vs.
22365.9%, P5NS). Unlike GLI, vasoconstriction induced by AVP or QUI
To test whether the disparity between GLI versus the was not offset by enhancing perfusion pulsatility (Fig. 3A, alternative constrictors was due to inhibition of NO-release
Discussion
This study provides the first demonstration that increases in the pulsatility of in vivo coronary perfusion can offset 1 coronary distal-vascular constrictor effects of K -chan-ATP nel blockade by glibenclamide. The capacity of higher pulsatility to offset GLI-induced constriction was largely eliminated by L-NMMA, supporting pulse-signalling NO release in offsetting GLI-induced vasoconstriction. In contrast, identical increases in pulsatility had no effect on net constriction by AVP or QUI, agents acting diffusely within the coronary vasculature. These results suggest a novel model whereby metabolic (i.e. distal vascular) regulation of coronary tone can be altered by mechanical stimuli from pulsatile perfusion via an NO-dependent mechanism.
Both basal coronary tone [3] and vasodilation associated with increased metabolic demand [8, 10] and ischemia [5] stimulation is nearly abolished [8] , while that associated with tachycardia pacing is partly inhibited by GLI [10] . In contrast, vasodilation is not attenuated by even high doses of glibenclamide in exercising conscious dogs [6, 7, 11, 12] nor with simulated exercise achieved by epinephrine and tachycardia pacing in anaesthetized dogs [4] . The present data, obtained with a pulse pressure mag- tion and rapid heart rates [4] . In the presence of K ATP control.
channel blockade and thus higher distal coronary resistance, higher flow pulsatility would likely result in greater by AVP or QUI, the vasodilator response to ACh (300 mg pulse-stretch and shear signalling throughout the vascular i.c.) was compared before and after infusion of each agent; bed. The enhanced mechanical signalling would trigger (Fig. 4A, left) . Furthermore, while the ACh-flow response on basal coronary flow but diminishes flow significantly at was substantially blunted by L-NMMA alone (P,0.001), higher pulsatility was first reported by Recchia et al. [16] , the addition of AVP did not modify this response (Fig. 4A, is confirmed in the present study, and is consistent with right, P.0.4 for interaction). Similar results were obtained augmented NO release at higher PPs. with QUI (data not shown).
Importantly, mean diastolic flow rose nearly 30% at We further tested whether the NO-dependence of PPhigher pulsatility in the presence of GLI despite a fall in induced flow augmentation was blunted by AVP (Fig. 4B) .
mean diastolic perfusion pressure. The fact that this As previously noted, AVP alone did not significantly alter diastolic flow augmentation was eliminated by L-NMMA the flow response to enhanced pulsatility. In contrast, further supports the role of NO release to this behaviour. L-NMMA alone reduced PP-induced flow elevation by Pulsatile stretch of endothelial cells [36, 37] and vascular 40% (P,0.05). AVP1L-NMMA altered this response segments [38] as well as enhanced phasic shear [39] are similarly to L-NMMA alone (P.0.8 for AVP-L-NMMA potent triggers of NO release. Moreover, rapid systolic interaction effect). These data show that disparities beflow increases produce greater shear in more constricted tween PP-induced flow elevation among GLI, AVP, and vessels. Thus, one might speculate that the combination of QUI, were unlikely due to inhibition of NOS signalling by enhanced phasic distension of more proximal arterioles and the latter two agents.
greater shear in constricted distal vessels results in suffi- are known to be altered by GLI. While no studies have and appears species and vascular site-specific [27, 41] . directly examined pulse-stretch stimulated NO release in Although we were unable to directly measure NO release conductance versus distal microvessels, data support that in these studies, data employing L-NMMA combined with basal NO release occurs more in the more proximal and AVP failed to support a direct inhibition of NO-dependent less in the distal microvessels [20] . Importantly, with even signalling by these agents. Results with QUI, which also 24% of the dose of L-NMMA employed in the present has effects throughout the coronary vasculature by inhib-1 study, Nishikawa et al. [40] recently reported that AChiting K [30] and K channels [31] and PLA [32- ca21 ATP 2 triggered dilation in vessels .100 m was abolished, 34, 42] , were similar to those with AVP. whereas that in even smaller microvessels persisted but at If the capacity for NO production was unimpeded by a reduced level.
AVP, as suggested by these results, then the disparity In contrast to GLI, neither AVP nor QUI-induced between PP-related flow changes versus GLI points to constrictor effects were reversed by increasing the pulregional differences in vessel tone. By generating diffuse satility of coronary perfusion. While GLI-mediated conrather than more selective distal constriction, AVP (and striction dominates in ,150 mm arterioles [20] [21] [22] , regula-QUI) may limit pulse-distension signalling in NO-respontion of tone by AVP and QUI is more diffuse due to sive vessels. An alternative explanation is that non-NO 21 21 multiple mechanisms. AVP increases intracellular Ca dependent pathways such as Ca -activated potassium isolated coronary beds perfused by enhanced pulsatile flow [16, 17] . As reported by Goto et al. [45] , and Recchia et al. [46] , increasing PP above 40 mm Hg dilates large and small resistance vessels by an endothelium-independent mechanism due to plastic properties of the vascular wall. In intact hearts, such distension would likely enhance proximal capacitance of the vascular bed, and combined with higher systolic perfusion pressures and distal constriction, increase systolic-period flow. Importantly, this flow contributes to net perfusion as demonstrated by previous comparisons to myocardial (microsphere) flow [25] . There are several potential limitations to our study that should be considered. Reduction of coronary flow due to regional vasoconstriction could have modified contractility of the locally perfused bed, altering the ventricular systolic flow impediment. Furthermore, AVP itself has been reported to induce moderate contractile depression in the dog [29] . However, the greatest extent of flow reduction was observed with combined GLI and L-NMMA, yet this yielded less flow enhancement with increased perfusion pulsatility than observed with GLI alone. Furthermore, similar reductions in flow were achieved with GLI, QUI shear cannot be measured in real-time and varies with the size and distensibility of the vascular bed, there is no channels are also importantly involved with the pulsecurrent method to servo-control arterial shear stress. More perfusion response and are more inhibited by AVP and detailed separation of these factors can be performed in QUI than by GLI. This hypothesis is supported by data vitro, but such preparations would not demonstrate the showing that both ACh-mediated and shear / stretch mepresent behaviour, given that it required coupling of diated vasodilation elicits a non-NO dependent hyperdifferent regions within the intact coronary vascular bed. polarizing factor [33, 34, 40, 41, 43] that is dependent on Finally, it would have been helpful to directly measure activation of K channels, channels that are partially of NO release in this model, rather than rely on response Ca21 inhibited by both AVP and QUI [27, 30] . NO may itself changes to NOS inhibition. Unfortunately, this has proven activate K channels [44] , and this mechanism could technically difficult due to the sub-optimal capacity to Ca21 also play a role in the ability of enhanced PP to offset sample venous blood purely derived from the isolated GLI-induced constriction. This would be less prominent perfused coronary artery, as well as to limitations in the with AVP and QUI as both can inhibit this pathway. In chemiluminescent assay techniques when examining par-1 contrast, more selective K blockade by GLI [6, 7] might tially hemolysed blood with elevated free plasma hemoglo- Regardless of the precise mechanism, the NO-production in conditions where pulsatile perfusion is present data suggest the GLI-PP interaction is specific, and elevated, and that NO-inhibition limits this change. not a generic response between coronary constriction and Enhancing pulsatile perfusion can offset the distal-resist-1 higher perfusion pulsatility. This is analogous to the ance vasoconstriction effects of the K blockade by a ATP specificity of adenosine and PP interaction recently remechanism related to NO release. Critical to this interported [17] .
action is the fact that mechanical-induced NO-release is 
